Received for publication May 23, 1958 THE selective uptake of 32p by malignant cells has been well known since Marshak (1940) reported that after administration of 32p to mice with cancer of the liver, the cancer cells contained more radioactive phosphorus than the normal liver cells. Later reports by Kenney, Marinelli and Woodward (1941) and by Marinelli and Goldschmidt (1942) on human tumour tissues confirmed Marshak's findings.
Since then a number of investigators have tried to establisti a method for diagnosing or locating a malignant tumour, based on the selective uptake of the radio-element. Thus, Low-Beer (1946) , Low-Beer and Bell (1956) , Bhattacharya et al. (1953) , Rigby-Jones, Smithers and Payne (1953) , Das-Gupta et al. (1956) experimented on breast tumours; Selverstone, Solomon and Sweet (1949) , Selverstone and White (1951) , Morley and Jefferson (1952) , Erickson, Larson and Gordon (1949) on brain tumours; Roswit, Sorrentino and Yalow (1950, 1956 ) studied testicular tumours; Klassen et al. (1952) endothoracic malignant tumours; Sturgis, DeMuylder and Meigs (1951) , cervical carcinoma; Cramer and Pabst (1952) , Cramer, Pabst and Treibs (1952) , stomach and other gastro-intestinal tumours. Thomas, Krohmer and Storaasli (1952) , Thomas et al. (1954) , Dunphy et al. (1954) , Palin and Tudway (1955), Terner, Leopold and Eisenberg (1956) , used 32p for the diagnosis of intraocular tumours. The method they used was based on comparing the 32p uptake of the tumour either with that of adjacent normal tissue, or with that of the opposite normal organ, e.g. eye, breast, testis etc.
The purpose of the present study was to determine whether selective uptake of 32p occurs in cancer of the cervix, and, if so, whether the progress of the cancer following radiotherapy can be assessed by this method.
MATERIAL
In the present study, 6 normal subjects and 26 patients with carcinoma of the cervix were investigated. Of these, 20 had received no treatment; 6 had been treated by radium insertions or high voltage X-ray treatment (H.V.T.), 1-3 weeks previously; 4 of these 6 had shown good clinical and histological response; 2 had not responded well. (For details see case reports below.)
METHOD
In all the 32 cases, 1 mc. Of 32P was administered intravenously, as orthophosphate in isotonic saline.
Twenty-four hours* after the administration of 32p, the patients were brought to the theatre, and under general anaesthesia, two biopsy specimens were obtained from the malignant tumour of the cervix. One specimen was fixed in formalin and sent to the pathological laboratory for histological examination. The other was used for radioactivity determination.
Special care was taken to avoid taking biopsy specimens from those cervical regions showing necrosis.
The specimen used for radioactivity determination was weighed as soon as possible after removal and dissolved in fuming nitric acid. The radioactivity contained in the solution was measured in a Twentieth Century liquid Geiger-Miiller counter, Type M.6. Counts were determined in duplicate for 100 seconds. A minimum of 500 counts above background was registered.
RESULTS
The results of radiophosphorus determination are shown graphically in Fig It will be seen that the radioactivity contained per gramme of tissue was appreciably higher in the 20 untreated tumour cases (mean 0-0432 ± 0-0051 (standard deviation) ,uc./g. of tissue) than in the 6 normal controls (mean 0-0078 ± 0-00192 /,c./g. of tissue). The 4 successfully treated patients gave after treatment values slightly higher than the normal controls (range 0-0145-0-0182 /,c./g. of tissue), but the 2 cases which had responded poorly to treatment still gave values as high as those of the untreated cases (0.034 and 0 039 usc./g. of tissue respectively).
No relationship was shown between the 32p uptake and either the weight or age of the patients.
DISCUSSION
In these studies the uptake of 32p was approximately six times as great in untreated cervical carcinoma as in normal cervical tissue.
The 32p uptake in the cervix of the successfully treated patients was approximately a third of that found in the tumour before treatment, but it was still higher than that of the normals. It is not known whether this slight increase is only temporary, and would return to normal in the course of time, as no investigations have been done on patients successfully treated some years ago.
There is the possibility that the reduction in 32p uptake noted after treatment might be due to a general response to irradiation.
The findings in patients who showed a poor response to treatment and still had a high uptake, indicate that a reduction in the uptake of radiophosphorus following treatment is associated with the disappearance of tumour and is not an independent manifestation of some general response of tissues to irradiation.
Patients of the same age group as the cancer patients were chosen for controls. Since most women in this group develop a form of chronic cervicitis, the 32p uptake in cervical carcinoma was compared with that in chronic cervicitis.
To compare the uptake of 32p in a tumour with that of adjacent " normal" tissue, as has been done by previous workers, is unlikely to be accurate, since there is some evidence that tissues in the neighbourhood of tumours may have undergone pre-cancerous changes which are undetectable histologically. This was first suggested by Halsted (1894) in the case of breast cancer, by Schottlaender and Kermauner (1912) in the case of cervical carcinoma, later by Schiller (1927) , and has been discussed recently by Novak and Novak (1956) , Hertig and Younge (1952) and Louros (1955) .
The determination of the 32p uptake in the cervix may prove to be of value for checking the result of radiotherapy, and perhaps also for detecting early malignant changes before these become evident histologically. SUMMARY 1. The uptake of 32p by cervical carcinoma has been studied in 20 patients before radiotherapy, in 6 patients after treatment and in 6 normal cervices.
2. The malignant tiss-ue takes up approximately six times more 32p per gramme of tissue than the normal.
3. In the treated carcinoma of the cervix, where the tumour has disappeared, the 32p uptake is reduced almost to normal values.
4. In two cases of carcinoma of the cervix, where the tumour had shown no response to irradiation, the 32p uptake was as high as that before treatment. 
